The FAA has proposed scrapping decades-old federal minimum standards for in-flight emergency medical kits, giving individual airlines broad discretion over which medications, diagnostic tools, and devices to stock. The AMA fired back with a formal comment letter, arguing that physicians who volunteer to help during in-flight emergencies deserve a reliable, consistent baseline — regardless of which airline the patient boarded.

AMA CEO John Whyte, MD, MPH, made clear the ask isn't for a flying ER — it's for a dependable safety floor. Emergency medicine experts echoed the sentiment, noting that in-flight medicine is uniquely challenging: unfamiliar patients, limited space, and potentially hours from the nearest hospital. Experts also flagged that current kits are based on outdated medical science and are long overdue for a refresh.

Key Takeaways:

• The AMA recommends an evidence-based national standard informed by the Aerospace Medical Association, with flexibility for airlines to exceed — not undercut — the baseline
• Long-haul overwater flights, where diversion isn't an option, may warrant enhanced kits beyond the standard minimum
• Epinephrine autoinjectors (EpiPens) are a flashpoint: the FAA has required epinephrine since 2003, but most airlines only stock vials — not the easy-to-use autoinjectors that reduce dosing errors in high-stress situations
• Sen. Tammy Duckworth called on all U.S. passenger airlines to include self-administrable epinephrine in their kits

Why it matters: When a medical emergency strikes at 30,000 feet, the tools available can mean the difference between life and death. Eliminating a national standard could create a patchwork of preparedness — putting both patients and volunteer clinicians at serious risk.